Overview

A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398

Status:
Completed

Trial end date:
2004-07-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to determine the long-term safety of asoprisnil 5 mg for 12 months in women with endometriosis from study M01-398.

Phase:

Phase 2

Details

Lead Sponsor:

Abbott